New Key Statistics Module, Z-Score and F-Score
NYSE:BIO Key Ratios
| Market Cap $ M | 7,889.61 |
| Enterprise Value $ M | 7,687.91 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 24.71 |
| Forward PE Ratio | 24.75 |
| Price/Book | 0.90 |
| Price/Sales | 3.02 |
| Price/Free Cash Flow | 37.08 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2,671.00 |
| EPS (TTM) $ | -21.49 |
| Beneish M-Score | -2.45 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -9.60 |
| EV-to-EBITDA | -11.74 |
| PEG | -- |
| Shares Outstanding M | 28.52 |
| Net Margin (%) | -23.86 |
| Operating Margin % | 12.65 |
| Pre-tax Margin (%) | -31.82 |
| Quick Ratio | 4.34 |
| Current Ratio | 5.83 |
| ROA % (ttm) | -5.03 |
| ROE % (ttm) | -7.08 |
| ROIC % (ttm) | 2.40 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.63 |
BIO Number of Guru Trades
BIO Volume of Guru Trades
Gurus Latest Trades with NYSE:BIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:BIO is held by these investors
Total 7
Bio-Rad Laboratories Inc Insider Transactions
No Available Data
News about NYSE:BIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers